2 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Metastatic Paranasal Sinus Squamous Cell Carcinoma: new trials by email Literature Review of Metastatic Paranasal Sinus Squamous Cell Carcinoma trials Research Report on Metastatic Paranasal Sinus Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation Audiometric Test, Interview - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Not applicable | Recruiting | Emory University | 118 | 2025-08-25 | 2026-07-16 |
| Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial Biospecimen Collection, Computed Tomography, Lovastatin - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | Phase 2 | Recruiting | Emory University | 28 | 2024-12-09 | 2026-02-11 |
Carcinoma (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Carcinoma (2) · Oropharyngeal Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2)
Carcinoma, Squamous Cell (2) · Head and Neck Neoplasms (2) · Laryngeal Diseases (2) · Mouth Diseases (2) · Nasopharyngeal Diseases (2) · Nasopharyngeal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Respiratory Tract Diseases (2)
Hearing (1) · Interviews as Topic (1) · Lovastatin (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · pembrolizumab (1)
Emory University (2)
United States (2)
Nicole C Schmitt, D, FACS (1) · Nicole C Schmitt, MD, FACS (1)
P30CA138292 (2), K24DC022077 (1)